Chemical Component Summary

Name2-(3,4-DIHYDRO-3-OXO-2H-BENZO[B][1,4]THIAZIN-2-YL)-N-HYDROXYACETAMIDE
IdentifiersN-hydroxy-2-[(2R)-3-oxo-4H-1,4-benzothiazin-2-yl]ethanamide
FormulaC10 H10 N2 O3 S
Molecular Weight238.263
TypeNON-POLYMER
Isomeric SMILESc1ccc2c(c1)NC(=O)[C@H](S2)CC(=O)NO
InChIInChI=1S/C10H10N2O3S/c13-9(12-15)5-8-10(14)11-6-3-1-2-4-7(6)16-8/h1-4,8,15H,5H2,(H,11,14)(H,12,13)/t8-/m1/s1
InChIKeyUKDWCJNGBPZOBU-MRVPVSSYSA-N

Chemical Details

Formal Charge0
Atom Count26
Chiral Atom Count1
Bond Count27
Aromatic Bond Count6

Drug Info: DrugBank

DrugBank IDDB02036 
Name2-(3,4-Dihydro-3-Oxo-2h-Benzo[B][1,4]Thiazin-2-Yl)-N-Hydroxyacetamide
Groups experimental
Synonyms2-(3,4-Dihydro-3-Oxo-2h-Benzo[B][1,4]Thiazin-2-Yl)-N-Hydroxyacetamide

Drug Targets

NameTarget SequencePharmacological ActionActions
Peptide deformylaseMAILNILEFPDPRLRTIAKPVEVVDDAVRQLIDDMFETMYEAPGIGLAAT...unknown
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
PubChem 448475